Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Genelux (GNLX) EBT Margin (2022 - 2024)

Genelux has reported EBT Margin over the past 3 years, most recently at 98125.0% for Q1 2024.

  • Quarterly results put EBT Margin at 98125.0% for Q1 2024, down 9249441.0% from a year ago — trailing twelve months through Dec 2024 was 385562.5% (down 36961956.0% YoY), and the annual figure for FY2025 was 406287.5%, down 1883750.0%.
  • EBT Margin for Q1 2024 was 98125.0% at Genelux, down from 5630.59% in the prior quarter.
  • Over the last five years, EBT Margin for GNLX hit a ceiling of 54.63% in Q3 2022 and a floor of 98125.0% in Q1 2024.
  • Median EBT Margin over the past 3 years was 5385.15% (2022), compared with a mean of 27210.17%.
  • Peak annual rise in EBT Margin hit -9249441bps in 2024, while the deepest fall reached -9249441bps in 2024.
  • Genelux's EBT Margin stood at 5139.71% in 2022, then fell by -10bps to 5630.59% in 2023, then plummeted by -1643bps to 98125.0% in 2024.
  • The last three reported values for EBT Margin were 98125.0% (Q1 2024), 5630.59% (Q1 2023), and 5139.71% (Q4 2022) per Business Quant data.